chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Incorrect route of product administration
Clinical narrative: Felt like they gave the vaccine subcutaneously; A spontaneous report was received from a consumer who was also a female patient of unspecified age who received Moderna's COVID-19 vaccine (mRNA-1273) and she felt like they gave the vaccine subcutaneously (incorrect route of product administration).  The patient's medical history was not reported.  Concomitant product use was not provided.  On an unspecified date, the patient received their first of two planned doses of mRNA-1273 (Lot number: 007M20A) for prophylaxis of COVID-19 infection.  During administration, the patient felt like they gave her the vaccine subcutaneously.   Action taken with mRNA-1273 in response to the event was not applicable.   The event of felt like they gave the vaccine subcutaneously was considered resolved.; Reporter's Comments: This report refers to a case of incorrect route of product administration for mRNA-1273 (lot # 007M20A) with no associated AEs reported.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Gait disturbance, Muscle spasms, Paraesthesia, Skin disorder
Clinical narrative: the same sensation and then it disappears; like a cramp; difficulty to walk; extreme tension in both legs; Tingling sensation around the right ear and in the hairline; It seems to be superficial; had the same sensation immediately after the second injection; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling sensation around the right ear and in the hairline), SKIN DISORDER (It seems to be superficial), FEELING ABNORMAL (had the same sensation immediately after the second injection), FEELING ABNORMAL (the same sensation and then it disappears) and MUSCLE SPASMS (like a cramp) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced FEELING ABNORMAL (had the same sensation immediately after the second injection). On an unknown date, the patient experienced PARAESTHESIA (Tingling sensation around the right ear and in the hairline), SKIN DISORDER (It seems to be superficial), FEELING ABNORMAL (the same sensation and then it disappears), MUSCLE SPASMS (like a cramp), GAIT DISTURBANCE (difficulty to walk) and MUSCLE SPASMS (extreme tension in both legs). At the time of the report, PARAESTHESIA (Tingling sensation around the right ear and in the hairline), SKIN DISORDER (It seems to be superficial), FEELING ABNORMAL (had the same sensation immediately after the second injection), FEELING ABNORMAL (the same sensation and then it disappears), MUSCLE SPASMS (like a cramp), GAIT DISTURBANCE (difficulty to walk) and MUSCLE SPASMS (extreme tension in both legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.    This case was linked to MOD-2021-042915, MOD-2021-026666 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Reporter contact details was updated.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Illness, Nausea
Clinical narrative: Woozy; very sick; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Woozy), ILLNESS (very sick) and NAUSEA (Nausea) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced DIZZINESS (Woozy), ILLNESS (very sick) and NAUSEA (Nausea). At the time of the report, DIZZINESS (Woozy), ILLNESS (very sick) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Rash, Rash papular, Urticaria
Clinical narrative: Right arm and legs looked like hives; Rash was burning; left arm got a raised rash; Left arm got itchy; Sore arm/left arm got tender; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Sore arm/left arm got tender), RASH PAPULAR (left arm got a raised rash), PRURITUS (Left arm got itchy), URTICARIA (Right arm and legs looked like hives) and RASH (Rash was burning) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm/left arm got tender). On 28-Feb-2021, the patient experienced RASH PAPULAR (left arm got a raised rash) and PRURITUS (Left arm got itchy). On 01-Mar-2021, the patient experienced URTICARIA (Right arm and legs looked like hives) and RASH (Rash was burning). At the time of the report, PAIN IN EXTREMITY (Sore arm/left arm got tender), RASH PAPULAR (left arm got a raised rash), PRURITUS (Left arm got itchy), URTICARIA (Right arm and legs looked like hives) and RASH (Rash was burning) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: sore arms; Tiredness; This spontaneous case was reported by an other and describes the occurrence of PAIN IN EXTREMITY (sore arms) and FATIGUE (Tiredness) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arms) and FATIGUE (Tiredness). At the time of the report, PAIN IN EXTREMITY (sore arms) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided by the reporter.  The treatment information was unknown.   This case was linked to US-MODERNATX, INC.-MOD-2021-026625.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-026625
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Hyperhidrosis, Muscular weakness, Thirst
Clinical narrative: weak, sweaty; weak,sweaty; weak,fatigue,thirsty; left shoulder is weak; weak,fatigue,thirsty; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak, sweaty), HYPERHIDROSIS (weak,sweaty), THIRST (weak,fatigue,thirsty), MUSCULAR WEAKNESS (left shoulder is weak) and FATIGUE (weak,fatigue,thirsty) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 006M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.   On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced ASTHENIA (weak, sweaty), HYPERHIDROSIS (weak,sweaty), THIRST (weak,fatigue,thirsty), MUSCULAR WEAKNESS (left shoulder is weak) and FATIGUE (weak,fatigue,thirsty). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ASTHENIA (weak, sweaty), HYPERHIDROSIS (weak,sweaty), THIRST (weak,fatigue,thirsty), MUSCULAR WEAKNESS (left shoulder is weak) and FATIGUE (weak,fatigue,thirsty) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: Little side effect; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Little side effect) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Historical condition reported).    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Little side effect). At the time of the report, ADVERSE REACTION (Little side effect) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a patient and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 35-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (3-4 glasses wine). Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BIOTIN;MINERALS NOS;NICOTINIC ACID;RETINOL;TOCOPHEROL;VITAMIN B NOS;VITAMIN D NOS] and FISH OIL for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 10-Jul-2021. On 25-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). On 25-Feb-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Vaccination site bruising, Vaccination site erythema, Vaccination site pain
Clinical narrative: injection site bruise; arm hurt; redness,persistent redness; raised injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (injection site bruise), VACCINATION SITE PAIN (arm hurt), VACCINATION SITE ERYTHEMA (redness,persistent redness) and INJECTION SITE SWELLING (raised injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE BRUISING (injection site bruise), VACCINATION SITE PAIN (arm hurt), VACCINATION SITE ERYTHEMA (redness,persistent redness) and INJECTION SITE SWELLING (raised injection site). At the time of the report, VACCINATION SITE BRUISING (injection site bruise), VACCINATION SITE PAIN (arm hurt), VACCINATION SITE ERYTHEMA (redness,persistent redness) and INJECTION SITE SWELLING (raised injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental overdose, Headache, Incorrect dose administered, Nausea, Vaccination site erythema
Clinical narrative: She was given 3 times (overdosed)/ Overdose on 2nd shot / 2nd shot was 2x dosage; Doses administered accidentally/ unintentionally  1 month apart; Left arm of injection has a big bump; Left arm of injection itchy; Left arm of injection painful; Left arm of injection red; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (She was given 3 times (overdosed)/ Overdose on 2nd shot / 2nd shot was 2x dosage), INCORRECT DOSE ADMINISTERED (Doses administered accidentally/ unintentionally  1 month apart), VACCINATION SITE MASS (Left arm of injection has a big bump), VACCINATION SITE PRURITUS (Left arm of injection itchy) and VACCINATION SITE PAIN (Left arm of injection painful) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 013L204) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroiditis, unspecified. Concomitant products included LEVOTHYROXINE for Thyroiditis, ESTRADIOL, PROGESTERONE and CALCIUM for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced ACCIDENTAL OVERDOSE (She was given 3 times (overdosed)/ Overdose on 2nd shot / 2nd shot was 2x dosage), INCORRECT DOSE ADMINISTERED (Doses administered accidentally/ unintentionally  1 month apart), VACCINATION SITE MASS (Left arm of injection has a big bump), VACCINATION SITE PRURITUS (Left arm of injection itchy), VACCINATION SITE PAIN (Left arm of injection painful), VACCINATION SITE ERYTHEMA (Left arm of injection red), NAUSEA (Nausea) and HEADACHE (Headache). The patient was treated with ACETAMINOPHEN at a dose of 1 dosage form. On 24-Feb-2021, ACCIDENTAL OVERDOSE (She was given 3 times (overdosed)/ Overdose on 2nd shot / 2nd shot was 2x dosage) and INCORRECT DOSE ADMINISTERED (Doses administered accidentally/ unintentionally  1 month apart) had resolved. At the time of the report, VACCINATION SITE MASS (Left arm of injection has a big bump), VACCINATION SITE PRURITUS (Left arm of injection itchy), VACCINATION SITE PAIN (Left arm of injection painful), VACCINATION SITE ERYTHEMA (Left arm of injection red), NAUSEA (Nausea) and HEADACHE (Headache) had resolved.            Treatment medication included Acetaminophen, Patient took it day before reporting night, and 2 more doses on the day of reporting. Concomitant medication also included unspecified thyroid medicines and eye medicines.  It was reported that the 1st shot was fine. 2nd shot was 2 dosage. In few days symptoms were gone and there was no recurrence of symptoms.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Clinical course information and event outcome updated to resolved.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass, Vaccination site pain, Vaccination site pruritus
Clinical narrative: She was given 3 times (overdosed)/ Overdose on 2nd shot / 2nd shot was 2x dosage; Doses administered accidentally/ unintentionally  1 month apart; Left arm of injection has a big bump; Left arm of injection itchy; Left arm of injection painful; Left arm of injection red; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (She was given 3 times (overdosed)/ Overdose on 2nd shot / 2nd shot was 2x dosage), INCORRECT DOSE ADMINISTERED (Doses administered accidentally/ unintentionally  1 month apart), VACCINATION SITE MASS (Left arm of injection has a big bump), VACCINATION SITE PRURITUS (Left arm of injection itchy) and VACCINATION SITE PAIN (Left arm of injection painful) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 013L204) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroiditis, unspecified. Concomitant products included LEVOTHYROXINE for Thyroiditis, ESTRADIOL, PROGESTERONE and CALCIUM for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced ACCIDENTAL OVERDOSE (She was given 3 times (overdosed)/ Overdose on 2nd shot / 2nd shot was 2x dosage), INCORRECT DOSE ADMINISTERED (Doses administered accidentally/ unintentionally  1 month apart), VACCINATION SITE MASS (Left arm of injection has a big bump), VACCINATION SITE PRURITUS (Left arm of injection itchy), VACCINATION SITE PAIN (Left arm of injection painful), VACCINATION SITE ERYTHEMA (Left arm of injection red), NAUSEA (Nausea) and HEADACHE (Headache). The patient was treated with ACETAMINOPHEN at a dose of 1 dosage form. On 24-Feb-2021, ACCIDENTAL OVERDOSE (She was given 3 times (overdosed)/ Overdose on 2nd shot / 2nd shot was 2x dosage) and INCORRECT DOSE ADMINISTERED (Doses administered accidentally/ unintentionally  1 month apart) had resolved. At the time of the report, VACCINATION SITE MASS (Left arm of injection has a big bump), VACCINATION SITE PRURITUS (Left arm of injection itchy), VACCINATION SITE PAIN (Left arm of injection painful), VACCINATION SITE ERYTHEMA (Left arm of injection red), NAUSEA (Nausea) and HEADACHE (Headache) had resolved.            Treatment medication included Acetaminophen, Patient took it day before reporting night, and 2 more doses on the day of reporting. Concomitant medication also included unspecified thyroid medicines and eye medicines.  It was reported that the 1st shot was fine. 2nd shot was 2 dosage. In few days symptoms were gone and there was no recurrence of symptoms.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Clinical course information and event outcome updated to resolved.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Hot; Rash around the injection site; Pink/rash is very pink; Swelling/raised; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot), VACCINATION SITE RASH (Rash around the injection site), VACCINATION SITE ERYTHEMA (Pink/rash is very pink) and VACCINATION SITE SWELLING (Swelling/raised) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Codeine).    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 28-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash around the injection site), VACCINATION SITE ERYTHEMA (Pink/rash is very pink) and VACCINATION SITE SWELLING (Swelling/raised). On 29-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Hot). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (topical) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Hot), VACCINATION SITE RASH (Rash around the injection site), VACCINATION SITE ERYTHEMA (Pink/rash is very pink) and VACCINATION SITE SWELLING (Swelling/raised) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Fatigue, Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: warm; itchy; injection site a rash from elbow to shoulder; sore arm; felt tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE RASH (injection site a rash from elbow to shoulder), AXILLARY PAIN (sore arm) and FATIGUE (felt tired) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.  On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 20-Feb-2021, the patient experienced AXILLARY PAIN (sore arm) and FATIGUE (felt tired). On 24-Feb-2021, the patient experienced VACCINATION SITE WARMTH (warm), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE RASH (injection site a rash from elbow to shoulder).   At the time of the report, VACCINATION SITE WARMTH (warm), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE RASH (injection site a rash from elbow to shoulder), AXILLARY PAIN (sore arm) and FATIGUE (felt tired) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It is reported that patient made a healing cream with steroid cream. Concomitant product use was not provided by the reporter.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site mass, Pruritus, Urticaria
Clinical narrative: red marks around her arm/ red circle around her arm; itchy on left arm; hard lump under the injection site; hives on left arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy on left arm), INJECTION SITE MASS (hard lump under the injection site), ERYTHEMA (red marks around her arm/ red circle around her arm) and URTICARIA (hives on left arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included DICLOFENAC (VOLTAREN [DICLOFENAC]) for Knee pain, LEVOTHYROXINE, DILTIAZEM, FAMOTIDINE, CHLORTHALIDONE, POTASSIUM, COLECALCIFEROL (VIT D [COLECALCIFEROL]) and ZINC for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced INJECTION SITE MASS (hard lump under the injection site) and URTICARIA (hives on left arm). On 24-Feb-2021, the patient experienced PRURITUS (itchy on left arm). On an unknown date, the patient experienced ERYTHEMA (red marks around her arm/ red circle around her arm). At the time of the report, PRURITUS (itchy on left arm), INJECTION SITE MASS (hard lump under the injection site), ERYTHEMA (red marks around her arm/ red circle around her arm) and URTICARIA (hives on left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.  Patient was due for second dose of vaccine on 09-MAR-2021.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hot flush
Clinical narrative: fatigue for 10 days after 1st dose; headache for 10 days after 1st dose; hot flashes for 10 days after 1st dose; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (fatigue for 10 days after 1st dose), HEADACHE (headache for 10 days after 1st dose) and HOT FLUSH (hot flashes for 10 days after 1st dose) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced FATIGUE (fatigue for 10 days after 1st dose), HEADACHE (headache for 10 days after 1st dose) and HOT FLUSH (hot flashes for 10 days after 1st dose). On 01-Feb-2021, FATIGUE (fatigue for 10 days after 1st dose), HEADACHE (headache for 10 days after 1st dose) and HOT FLUSH (hot flashes for 10 days after 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication of the patient included Ibuprofen, Nyquil and Benadryl. No concomitant medications of the patient were reported.   Reporter did not allow further contact
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included GVHD and Stem cell transplant. Concomitant products included PREDNISONE, IBRUTINIB, AMOXICILLIN, ACYCLOVIR [ACICLOVIR], COLECALCIFEROL (VIT D [COLECALCIFEROL]) and LEVOTHYROXINE SODIUM (LEVOXYL) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore left arm). At the time of the report, PAIN IN EXTREMITY (sore left arm) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported.   This case was linked to MOD-2021-026779 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Urticaria, Vaccination site pain
Clinical narrative: bumps all over head, arms, legs, back which looked like mosquito bites with minor irritation; Felt a little ill; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt a little ill), VACCINATION SITE PAIN (Sore arm) and URTICARIA (bumps all over head, arms, legs, back which looked like mosquito bites with minor irritation) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.  On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 20-Feb-2021, the patient experienced MALAISE (Felt a little ill) and VACCINATION SITE PAIN (Sore arm).   On 23-Feb-2021, the patient experienced URTICARIA (bumps all over head, arms, legs, back which looked like mosquito bites with minor irritation).   On 25-Feb-2021, MALAISE (Felt a little ill), VACCINATION SITE PAIN (Sore arm) and URTICARIA (bumps all over head, arms, legs, back which looked like mosquito bites with minor irritation) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medication were provided by the reporter.   No treatment information was provided.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Haematoma, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: significant itching at the injection site; redness from elbow to below my shoulder; looked like a hematoma; soreness; redness at the injection site; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (soreness), VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE PRURITUS (significant itching at the injection site), ERYTHEMA (redness from elbow to below my shoulder) and HAEMATOMA (looked like a hematoma) in a 92-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE PAIN (soreness) and VACCINATION SITE ERYTHEMA (redness at the injection site). On 17-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (significant itching at the injection site), ERYTHEMA (redness from elbow to below my shoulder) and HAEMATOMA (looked like a hematoma). The patient was treated with BENZOCAINE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (soreness), VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE PRURITUS (significant itching at the injection site), ERYTHEMA (redness from elbow to below my shoulder) and HAEMATOMA (looked like a hematoma) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Pain in extremity, Petechiae, Pyrexia
Clinical narrative: Pain on left arm; petechiae; pyrexia; nausea; vomiting; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain on left arm), PETECHIAE (petechiae), PYREXIA (pyrexia), NAUSEA (nausea) and VOMITING (vomiting) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain on left arm), PETECHIAE (petechiae), PYREXIA (pyrexia), NAUSEA (nausea), VOMITING (vomiting) and CHILLS (chills). At the time of the report, PAIN IN EXTREMITY (Pain on left arm), PETECHIAE (petechiae), PYREXIA (pyrexia), NAUSEA (nausea), VOMITING (vomiting) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Pain on left arm; petechiae; pyrexia; nausea; vomiting; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain on left arm), PETECHIAE (petechiae), PYREXIA (pyrexia), NAUSEA (nausea) and VOMITING (vomiting) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain on left arm), PETECHIAE (petechiae), PYREXIA (pyrexia), NAUSEA (nausea), VOMITING (vomiting) and CHILLS (chills). At the time of the report, PAIN IN EXTREMITY (Pain on left arm), PETECHIAE (petechiae), PYREXIA (pyrexia), NAUSEA (nausea), VOMITING (vomiting) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: arm is still reddish and warm; arm is still reddish and warm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (arm is still reddish and warm) and VACCINATION SITE WARMTH (arm is still reddish and warm) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 13-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (arm is still reddish and warm) and VACCINATION SITE WARMTH (arm is still reddish and warm).   At the time of the report, VACCINATION SITE ERYTHEMA (arm is still reddish and warm) and VACCINATION SITE WARMTH (arm is still reddish and warm) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pregnancy test, Ultrasound abdomen
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a physician and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 33-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (2-4 drinks a week) on 15-Dec-2020. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from December 2020 to an unknown date for Pregnancy.    On 25-Feb-2021 at 1:20 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 20-Nov-2020 and the estimated date of delivery was 27-Aug-2021. On 25-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirteenth week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 25-Feb-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Dec-2020, Pregnancy test: positive (Positive) positive. On 22-Jan-2021, Ultrasound abdomen: normal (normal) NO ABNORMAL FINDINGS. On 12-Feb-2021, Ultrasound abdomen: normal (normal) NO ABNORMAL FINDINGS.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vaccination site pain
Clinical narrative: skin is sensitive to touch, they feel sore all over, but more like a nerve endings kind of thing.; armpit had a painful lump, like a swollen lymph node.; This spontaneous case was reported by a health care professional and describes the occurrence of LYMPHADENOPATHY (armpit had a painful lump, like a swollen lymph node.) and VACCINATION SITE PAIN (skin is sensitive to touch, they feel sore all over, but more like a nerve endings kind of thing.) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), VITAMIN B COMPLEX, FISH OIL and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021 at 1:59 PM, the patient experienced LYMPHADENOPATHY (armpit had a painful lump, like a swollen lymph node.). On 25-Feb-2021, the patient experienced VACCINATION SITE PAIN (skin is sensitive to touch, they feel sore all over, but more like a nerve endings kind of thing.). The patient was treated with PARACETAMOL (TYLENOL) for Skin discomfort, at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (armpit had a painful lump, like a swollen lymph node.) and VACCINATION SITE PAIN (skin is sensitive to touch, they feel sore all over, but more like a nerve endings kind of thing.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Pain in extremity, Pruritus, Vaccination site erythema, Vaccination site induration
Clinical narrative: burning a little bit but nothing out of the ordinary; itching; little sore; it was a pretty big round red spot. it was itchy and hard, and red; it was a pretty big round red spot. it was itchy and hard, and red; it was a pretty big round red spot. it was itchy and hard, and red; This spontaneous case was reported by a patient and describes the occurrence of BURNING SENSATION (burning a little bit but nothing out of the ordinary), PRURITUS (itching), PAIN IN EXTREMITY (little sore), VACCINATION SITE INDURATION (it was a pretty big round red spot. it was itchy and hard, and red) and VACCINATION SITE PRURITUS (it was a pretty big round red spot. it was itchy and hard, and red) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high and Asthma. Concomitant products included ERGOCALCIFEROL (VITAMIN D [ERGOCALCIFEROL]) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced BURNING SENSATION (burning a little bit but nothing out of the ordinary), PRURITUS (itching), PAIN IN EXTREMITY (little sore), VACCINATION SITE INDURATION (it was a pretty big round red spot. it was itchy and hard, and red), VACCINATION SITE PRURITUS (it was a pretty big round red spot. it was itchy and hard, and red) and VACCINATION SITE ERYTHEMA (it was a pretty big round red spot. it was itchy and hard, and red). At the time of the report, BURNING SENSATION (burning a little bit but nothing out of the ordinary), PRURITUS (itching), PAIN IN EXTREMITY (little sore), VACCINATION SITE INDURATION (it was a pretty big round red spot. it was itchy and hard, and red), VACCINATION SITE PRURITUS (it was a pretty big round red spot. it was itchy and hard, and red) and VACCINATION SITE ERYTHEMA (it was a pretty big round red spot. it was itchy and hard, and red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: burning a little bit but nothing out of the ordinary; itching; little sore; it was a pretty big round red spot. it was itchy and hard, and red; it was a pretty big round red spot. it was itchy and hard, and red; it was a pretty big round red spot. it was itchy and hard, and red; This spontaneous case was reported by a patient and describes the occurrence of BURNING SENSATION (burning a little bit but nothing out of the ordinary), PRURITUS (itching), PAIN IN EXTREMITY (little sore), VACCINATION SITE INDURATION (it was a pretty big round red spot. it was itchy and hard, and red) and VACCINATION SITE PRURITUS (it was a pretty big round red spot. it was itchy and hard, and red) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high and Asthma. Concomitant products included ERGOCALCIFEROL (VITAMIN D [ERGOCALCIFEROL]) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced BURNING SENSATION (burning a little bit but nothing out of the ordinary), PRURITUS (itching), PAIN IN EXTREMITY (little sore), VACCINATION SITE INDURATION (it was a pretty big round red spot. it was itchy and hard, and red), VACCINATION SITE PRURITUS (it was a pretty big round red spot. it was itchy and hard, and red) and VACCINATION SITE ERYTHEMA (it was a pretty big round red spot. it was itchy and hard, and red). At the time of the report, BURNING SENSATION (burning a little bit but nothing out of the ordinary), PRURITUS (itching), PAIN IN EXTREMITY (little sore), VACCINATION SITE INDURATION (it was a pretty big round red spot. it was itchy and hard, and red), VACCINATION SITE PRURITUS (it was a pretty big round red spot. it was itchy and hard, and red) and VACCINATION SITE ERYTHEMA (it was a pretty big round red spot. it was itchy and hard, and red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersomnia, Influenza like illness, Pain, Vomiting
Clinical narrative: Flu-like symptoms; slept for an entire day; Bad Aches; throwing up; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), HYPERSOMNIA (slept for an entire day), PAIN (Bad Aches) and VOMITING (throwing up) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No medical history was reported.     On 21-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), HYPERSOMNIA (slept for an entire day), PAIN (Bad Aches) and VOMITING (throwing up). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), HYPERSOMNIA (slept for an entire day), PAIN (Bad Aches) and VOMITING (throwing up) outcome was unknown.            No concomitant medications were provided by the reporter.   No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Pain in extremity
Clinical narrative: Arm was heavy; Her pain level was 3; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Arm was heavy) and PAIN IN EXTREMITY (Her pain level was 3) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical history provided.     On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (Arm was heavy) and PAIN IN EXTREMITY (Her pain level was 3). At the time of the report, LIMB DISCOMFORT (Arm was heavy) and PAIN IN EXTREMITY (Her pain level was 3) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient did not do any treatment. No concomitant medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Live follow up received on 21-Apr-2021: Patient said she was doing fine but not sure about getting 2nd dose. She did not want further follow up.
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: Chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced CHILLS (Chills). At the time of the report, CHILLS (Chills) outcome was unknown.            Concomitant medication and treatment information were not reported.  Action taken with mRNA-1273 in response to the event was Not Applicable
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Panic attack, Pyrexia, SARS-CoV-2 antibody test
Clinical narrative: winded fast; panic attacks; fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (winded fast), PANIC ATTACK (panic attacks), PYREXIA (fever) and FATIGUE (fatigue) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     The patient's past medical history included Bronchitis (started on antibiotics) and COVID-19 (11 days quarantined.) on 15-Jan-2021. Concurrent medical conditions included Fibromyalgia, Anxiety, Obsessive-compulsive disorder, Stomach discomfort and Hypertension.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced DYSPNOEA (winded fast), PANIC ATTACK (panic attacks), PYREXIA (fever) and FATIGUE (fatigue). The patient was treated with COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (winded fast), PANIC ATTACK (panic attacks), PYREXIA (fever) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, SARS-CoV-2 antibody test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included medications for blood pressure, OCD and Anxiety, Stomach issues.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: No new information.